Onco Therapies

Strides Arcolab gets USFDA approval for generic cancer drug

Strides Arcolab today said its wholly-owned arm Onco Therapies has received approval from US health regulator for its generic version of cancer drug Ifosfamide.

Strides Arcolab surges 3% on US FDA nod for Topotecan

Pharmaceutical company Strides Arcolab gained 3% intraday on Wednesday as its wholly owned subsidiary Onco Therapies has received ANDA (abbreviated new drug application) approval from the US FDA for Topotecan Hydrochloride injection 4 mg (base), packaged in single dose vials.

Strides Arcolab gets USFDA nod for generic anti-cancer drug

Pharma firm Strides Arcolab today said its subsidiary Onco Therapies Ltd has received final approval from the US health regulator for its generic version of Oxaliplatin injection used for treating cancer.

Strides Arcolab gets USFDA nod for Fluorouracil Injection

Drug firm Strides Arcolab today said it has received approvals from the US health regulator for generic Fluorouracil Injection used for treating several types of cancer.

Strides Arcolab gets two more US FDA nods for cancer drugs

Onco Therapies, the unit of pharma company Strides Arcolab, has received US FDA approval for Carboplatin injection 10 mg/ml packaged in pharmacy bulk packs of 1000 mg/100 ml [aqueous solution].

Strides Arcolab gets US FDA nod for cancer treatment drugs

Pharma company Strides Arcolab’s unit Onco Therapies has received US Food and Drugs Administration (FDA) approval for Paclitaxel injection used to treat ovarian cancer, breast cancer and non-small cell lung cancer.

Strides Arcolab arm gets US FDA nod for chemotherapy drug

Onco Therapies, a wholly owned unit of Strides Arcolab, has received US Foods and Drugs Administration approval for Gemcitabine injection, a generic version chemotherapy drug Gemzar marketed by Eli Lilly and Co.